Actinium Pharmaceuticals, Inc.
ATNM
$1.25
$0.021.29%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 36.47M | 42.13M | 48.00M | 53.39M | 59.93M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.27M | 1.13M | 1.38M | 975.00K | 1.10M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 37.74M | 43.26M | 49.38M | 54.37M | 61.03M |
|
|
|||||
| Total Current Assets | 37.74M | 43.26M | 49.38M | 54.37M | 61.03M |
| Net Property, Plant & Equipment | 2.08M | 1.84M | 2.06M | 1.45M | 1.66M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 339.00K | 337.00K | 335.00K | 332.00K | 329.00K |
| Total Assets | 40.16M | 45.44M | 51.78M | 56.15M | 63.02M |
|
|
|||||
| Total Accounts Payable | 8.51M | 6.62M | 7.25M | 6.22M | 7.71M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 746.00K | 734.00K | 722.00K | 610.00K | 600.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 9.26M | 7.35M | 7.97M | 6.83M | 8.31M |
|
|
|||||
| Total Current Liabilities | 9.26M | 7.35M | 7.97M | 6.83M | 8.31M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 595.00K | 785.00K | 972.00K | 533.00K | 690.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 35.00M | 35.00M | 35.00M | 35.00M |
| Total Liabilities | 9.86M | 43.13M | 43.94M | 42.37M | 44.00M |
|
|
|||||
| Common Stock & APIC | 417.70M | 417.58M | 417.57M | 417.56M | 417.66M |
| Retained Earnings | -387.33M | -415.24M | -409.71M | -403.77M | -398.64M |
| Treasury Stock & Other | -60.00K | -39.00K | -20.00K | -- | -- |
| Total Common Equity | 30.30M | 2.30M | 7.83M | 13.78M | 19.01M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 30.30M | 2.30M | 7.83M | 13.78M | 19.01M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 30.30M | 2.30M | 7.83M | 13.78M | 19.01M |
|
|
|||||